PATENT CLAIM ANALYSIS

Application Number: 15780618
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "675000"]

Abstract:
Provided herein are compounds that act as histone deacetylase (HDAC) inhibitors, and can affect expression of genes in vivo and in vitro. These HDAC inhibitors are generally volatile compounds that can be administered as a gas or vapor. Such inhibitors can be used as therapeutics for numerous disease conditions, such as a variety of cancers, neural degenerative diseases, neurological diseases, senescence, and infectious diseases.

Claim (Index 10):
The method of  claim 1 , wherein the volatile HDAC inhibitor compound is 2-methyl-2-propenal, methyl vinyl ether, methyl formate, 1,4-pentadien-3-one, furfural, dimethyl carbonate, methyl dimethyl acrylate, methyl acrylate, methyl methacrylate, isobutyl formate, isoamyl formate, gamma-valerolactone, propylene carbonate, methyl butyrate, 2-pentanone, propylene acetal, isobutyl acetate, 2,3-butane diol, 3-methyl-3-buten-2-one, allyl acetone, 4-methyl-3-penten-2-one, mesityl oxide, isopropyl 2-propenoate, gamma-butyrolactone, 3-hydroxybutanoic acid lactone, 2-methyl-1-penten-3-one, propyl propionate, acetic acid, propionic acid, 2,3-pentanedione, 2-butanone, diacetyl, or any combinations thereof.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 93.0
- Lexical Diversity: 1.53061
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15540316', '12285380', '11920909', '15934299', '13747044']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7938983695308707
- 35 USC 102 Novelty (BERT): 0.5123782120783635
- Combined Prediction Score: 0.76574635378562
- Mean Citation Score: 271.448808
- Max Citation Score: 281.13092
- Similarity Product: 194.04757880143163

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test